Abstract
Maintenance of the antioxidant activity of selenoproteins is one potential mechanism of the beneficial health effects of selenium. Selenoprotein P is the primary selenium distribution protein of the body as well as the major selenium containing protein in serum. The transcriptional regulation of selenoprotein P is of interest since the extrahepatic expression of this gene has demonstrated differentiation-dependent expression in development as well as under different disease states. SEPP1 displays patterned expression in numerous tissues during development and the loss of SEPP1 expression has been observed in malignancy. In addition, factors that influence inflammatory processes like cytokines and their regulators have been implicated in selenoprotein P transcriptional control. Herein, we identify a retinoid responsive element and describe a mechanism where the glucocorticoid receptor negatively regulates expression of selenoprotein P. Luciferase reporter assays and quantitative PCR were used to measure selenoprotein P transcription in engineered HEK-293 cells. When stimulated with ecdysone analogs, selenoprotein P expression was increased with the use of a fusion transcription factor that contains the glucocorticoid receptor DNA binding domain, an ecdysone ligand-binding domain, and a strong transactivation domain as well as the retinoid X receptor. The native glucocorticoid receptor inhibited selenoprotein P transactivation, and selenoprotein P was further attenuated in the presence of dexamethasone. Our results may provide insight into a potential mechanism by which selenium is redistributed during development, differentiation or under conditions of critical illness, where glucocorticoid levels are typically increased.
Similar content being viewed by others
Abbreviations
- Dex:
-
Dexamethasone
- DMSO:
-
Dimethyl sulfoxide
- EtOH:
-
Ethanol
- GR:
-
Glucocorticoid receptor
- FoxO1a:
-
Forkhead box, class O1a
- GRE:
-
Glucocorticoid response element
- HNF-4α:
-
Hepatocyte nuclear factor-4α
- PCR:
-
Polymerase chain reaction
- PGC-1α:
-
Peroxisomal proliferator activated receptor-γ coactivator 1α
- PonA:
-
Ponasterone A
- RRE:
-
Retinoid responsive element
- RXR:
-
Retinoid X receptor
- SelP:
-
Selenoprotein P gene product
- SEPP1:
-
Selenoprotein P gene
- VgEcR:
-
Ecdysone-inducible fusion transcription factor
References
Akesson B, Bellew T, Burk RF (1994) Purification of selenoprotein P from human plasma. Biochim Biophys Acta 1204(2):243–249
Al-Taie OH, Seufert J, Mork H, Treis H, Mentrup B, Thalheimer A, Starostik P, Abel J, Scheurlen M, Kohrle J et al (2002) A complex DNA-repeat structure within the Selenoprotein P promoter contains a functionally relevant polymorphism and is genetically unstable under conditions of mismatch repair deficiency. Eur J Hum Genet 10(9):499–504. doi:10.1038/sj.ejhg.5200811
Al-Taie OH, Uceyler N, Eubner U, Jakob F, Mork H, Scheurlen M, Brigelius-Flohe R, Schottker K, Abel J, Thalheimer A et al (2004) Expression profiling and genetic alterations of the selenoproteins GI-GPx and SePP in colorectal carcinogenesis. Nutr Cancer 48(1):6–14. doi:10.1207/s15327914nc4801_2
Angstwurm MW, Gaertner R (2006) Practicalities of selenium supplementation in critically ill patients. Curr Opin Clin Nutr Metab Care 9(3):233–238. doi:10.1097/01.mco.0000222105.30795.7f
Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, Strauss R, Meier-Hellmann A, Insel R, Radke J et al (2007) Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 35(1):118–126. doi:10.1097/01.CCM.0000251124.83436.0E
Aranda A, Pascual A (2001) Nuclear hormone receptors and gene expression. Physiol Rev 81(3):1269–1304
Bailly A, Torres-Padilla ME, Tinel AP, Weiss MC (2001) An enhancer element 6 kb upstream of the mouse HNF4alpha1 promoter is activated by glucocorticoids and liver-enriched transcription factors. Nucleic Acids Res 29(17):3495–3505. doi:10.1093/nar/29.17.3495
Beato M, Chalepakis G, Schauer M, Slater EP (1989) DNA regulatory elements for steroid hormones. J Steroid Biochem 32(5):737–747. doi:10.1016/0022-4731(89)90521-9
Bedo G, Santisteban P, Aranda A (1989) Retinoic acid regulates growth hormone gene expression. Nature 339(6221):231–234. doi:10.1038/339231a0
Benoit G, Cooney A, Giguere V, Ingraham H, Lazar M, Muscat G, Perlmann T, Renaud JP, Schwabe J, Sladek F et al (2006) International Union of Pharmacology. LXVI. Orphan nuclear receptors. Pharmacol Rev 58(4):798–836. doi:10.1124/pr.58.4.10
Bermano G, Nicol F, Dyer JA, Sunde RA, Beckett GJ, Arthur JR, Hesketh JE (1996) Selenoprotein gene expression during selenium-repletion of selenium-deficient rats. Biol Trace Elem Res 51(3):211–223. doi:10.1007/BF02784076
Brown KM, Arthur JR (2001) Selenium, selenoproteins and human health: a review. Public Health Nutr 4B(2):593–599. doi:10.1079/PHN2001143
Burk RF, Hill KE (2005) Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annu Rev Nutr 25:215–235. doi:10.1146/annurev.nutr.24.012003.132120
Burk RF, Hill KE, Motley AK, Austin LM, Norsworthy BK (2006) Deletion of selenoprotein P upregulates urinary selenium excretion and depresses whole-body selenium content. Biochim Biophys Acta 1760(12):1789–1793
Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG et al (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276(24):1957–1963. doi:10.1001/jama.276.24.1957
Cordray P, Doyle K, Edes K, Moos PJ, Fitzpatrick FA (2007) Oxidation of 2-Cys-peroxiredoxins by arachidonic acid peroxide metabolites of lipoxygenases and cyclooxygenase-2. J Biol Chem 282(45):32623–32629. doi:10.1074/jbc.M704369200
Crestani M, Sadeghpour A, Stroup D, Galli G, Chiang JY (1998) Transcriptional activation of the cholesterol 7 alpha-hydroxylase gene (CYP7A) by nuclear hormone receptors. J Lipid Res 39(11):2192–2200
Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA, Chinnaiyan AM (2001) Delineation of prognostic biomarkers in prostate cancer. Nature 412(6849):822–826. doi:10.1038/35090585
Diwadkar-Navsariwala V, Diamond AM (2004) The link between selenium and chemoprevention: a case for selenoproteins. J Nutr 134(11):2899–2902
Dreher I, Jakobs TC, Kohrle J (1997) Cloning and characterization of the human selenoprotein P promoter. Response of selenoprotein P expression to cytokines in liver cells. J Biol Chem 272(46):29364–29371. doi:10.1074/jbc.272.46.29364
Flamant F, Baxter JD, Forrest D, Refetoff S, Samuels H, Scanlan TS, Vennstrom B, Samarut J (2006) International Union of Pharmacology. LIX. The pharmacology and classification of the nuclear receptor superfamily: thyroid hormone receptors. Pharmacol Rev 58(4):705–711. doi:10.1124/pr.58.4.3
Germain P, Staels B, Dacquet C, Spedding M, Laudet V (2006) Overview of nomenclature of nuclear receptors. Pharmacol Rev 58(4):685–704. doi:10.1124/pr.58.4.2
Ghassabeh GH, De Baetselier P, Brys L, Noel W, Van Ginderachter JA, Meerschaut S, Beschin A, Brombacher F, Raes G (2006) Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo in different pathologic conditions. Blood 108(2):575–583. doi:10.1182/blood-2005-04-1485
Gougat C, Jaffuel D, Gagliardo R, Henriquet C, Bousquet J, Demoly P, Mathieu M (2002) Overexpression of the human glucocorticoid receptor alpha and beta isoforms inhibits AP-1 and NF-kappaB activities hormone independently. J Mol Med 80(5):309–318. doi:10.1007/s00109-001-0302-6
Hamrahian AH, Oseni TS, Arafah BM (2004) Measurements of serum free cortisol in critically ill patients. N Engl J Med 350(16):1629–1638. doi:10.1056/NEJMoa020266
Hill KE, Zhou J, McMahan WJ, Motley AK, Atkins JF, Gesteland RF, Burk RF (2003) Deletion of selenoprotein P alters distribution of selenium in the mouse. J Biol Chem 278(16):13640–13646. doi:10.1074/jbc.M300755200
Hollenbach B, Morgenthaler NG, Struck J, Alonso C, Bergmann A, Kohrle J, Schomburg L (2008) New assay for the measurement of selenoprotein P as a sepsis biomarker from serum. J Trace Elem Med Biol 22(1):24–32. doi:10.1016/j.jtemb.2007.11.003
Howard MT, Moyle MW, Aggarwal G, Carlson BA, Anderson CB (2007) A recoding element that stimulates decoding of UGA codons by Sec tRNA[Ser]Sec. RNA 13(6):912–920. doi:10.1261/rna.473907
Irons R, Carlson BA, Hatfield DL, Davis CD (2006) Both selenoproteins and low molecular weight selenocompounds reduce colon cancer risk in mice with genetically impaired selenoprotein expression. J Nutr 136(5):1311–1317
Jiang C, Xuan Z, Zhao F, Zhang MQ (2007) TRED: a transcriptional regulatory element database, new entries and other development. Nucleic Acids Res 35(Database issue):D137–D140. doi:10.1093/nar/gkl1041
Kryukov GV, Gladyshev VN (2000) Selenium metabolism in zebrafish: multiplicity of selenoprotein genes and expression of a protein containing 17 selenocysteine residues. Genes Cells 5(12):1049–1060. doi:10.1046/j.1365-2443.2000.00392.x
Lazzeri C, Tarquini R, Giunta F, Gensini GF (2009) Glucose dysmetabolism and prognosis in critical illness. Intern Emerg Med 4(2):147–156
Lee SR, Yon JM, Baek IJ, Kim MR, Park CG, Lee BJ, Yun YW, Nam SY (2008) Spatiotemporal expression of the selenoprotein P gene in postimplantational mouse embryos. Int J Dev Biol 52(7):1005–1011. doi:10.1387/ijdb.082656sl
Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA et al (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301(1):39–51. doi:10.1001/jama.2008.864
Lucas B, Grigo K, Erdmann S, Lausen J, Klein-Hitpass L, Ryffel GU (2005) HNF4alpha reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinoma. Oncogene 24(42):6418–6431
Madeja Z, Sroka J, Nystrom C, Bjorkhem-Bergman L, Nordman T, Damdimopoulos A, Nalvarte I, Eriksson LC, Spyrou G, Olsson JM et al (2005) The role of thioredoxin reductase activity in selenium-induced cytotoxicity. Biochem Pharmacol 69(12):1765–1772. doi:10.1016/j.bcp.2005.02.023
Marano G, Fischioni P, Graziano C, Iannone M, Morisi G (1990) Increased serum selenium levels in patients under corticosteroid treatment. Pharmacol Toxicol 67(2):120–122. doi:10.1111/j.1600-0773.1990.tb00796.x
Mark SD, Qiao YL, Dawsey SM, Wu YP, Katki H, Gunter EW, Fraumeni JF Jr, Blot WJ, Dong ZW, Taylor PR (2000) Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst 92(21):1753–1763. doi:10.1093/jnci/92.21.1753
Mostert V, Dreher I, Kohrle J, Wolff S, Abel J (2001) Modulation of selenoprotein P expression by TGF-beta(1) is mediated by Smad proteins. Biofactors 14(1–4):135–142. doi:10.1002/biof.5520140118
Nakshatri H, Bhat-Nakshatri P (1998a) Multiple parameters determine the specificity of transcriptional response by nuclear receptors HNF-4, ARP-1, PPAR, RAR and RXR through common response elements. Nucleic Acids Res 26(10):2491–2499. doi:10.1093/nar/26.10.2491
Nakshatri H, Bhat-Nakshatri P (1998b) Multiple parameters determine the specificity of transcriptional response by nuclear receptors HNF-4, ARP-1, PPAR, RAR and RXR through common response elements. Nucleic Acids Res 26(10):2491–2499. doi:10.1093/nar/26.10.2491
Nakshatri H, Chambon P (1994) The directly repeated RG(G/T)TCA motifs of the rat and mouse cellular retinol-binding protein II genes are promiscuous binding sites for RAR, RXR, HNF-4, and ARP-1 homo- and heterodimers. J Biol Chem 269(2):890–902
Nomura AM, Lee J, Stemmermann GN, Combs GF Jr (2000) Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 9(9):883–887
Nordeen SK, Suh BJ, Kuhnel B, Hutchison CD (1990) Structural determinants of a glucocorticoid receptor recognition element. Mol Endocrinol 4(12):1866–1873. doi:10.1210/mend-4-12-1866
Oehme I, Bosser S, Zornig M (2006) Agonists of an ecdysone-inducible mammalian expression system inhibit Fas Ligand- and TRAIL-induced apoptosis in the human colon carcinoma cell line RKO. Cell Death Differ 13(2):189–201. doi:10.1038/sj.cdd.4401730
Panguluri SK, Li B, Hormann RE, Palli SR (2007) Effect of ecdysone receptor gene switch ligands on endogenous gene expression in 293 cells. FEBS J 274(21):5669–5689. doi:10.1111/j.1742-4658.2007.06089.x
Peretz A, Neve J, Vertongen F, Famaey JP, Molle L (1987) Selenium status in relation to clinical variables and corticosteroid treatment in rheumatoid arthritis. J Rheumatol 14(6):1104–1107
Ramji DP, Foka P (2002) CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 365(Pt 3):561–575
Renko K, Werner M, Renner-Muller I, Cooper TG, Yeung CH, Hollenbach B, Scharpf M, Kohrle J, Schomburg L, Schweizer U (2008) Hepatic selenoprotein P (SePP) expression restores selenium transport and prevents infertility and motor-incoordination in Sepp-knockout mice. Biochem J 409(3):741–749. doi:10.1042/BJ20071172
Renko K, Hofmann PJ, Stoedter M, Hollenbach B, Behrends T, Kohrle J, Schweizer U, Schomburg L (2009) Down-regulation of the hepatic selenoprotein biosynthesis machinery impairs selenium metabolism during the acute phase response in mice. Faseb J 23(6):1758–1765
Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM (2004) ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6(1):1–6
Rudiger JJ, Roth M, Bihl MP, Cornelius BC, Johnson M, Ziesche R, Block LH (2002) Interaction of C/EBPalpha and the glucocorticoid receptor in vivo and in nontransformed human cells. FASEB J 16(2):177–184. doi:10.1096/fj.01-0226com
Saez E, Nelson MC, Eshelman B, Banayo E, Koder A, Cho GJ, Evans RM (2000) Identification of ligands and coligands for the ecdysone-regulated gene switch. Proc Natl Acad Sci USA 97(26):14512–14517. doi:10.1073/pnas.260499497
Schomburg L, Schweizer U, Holtmann B, Flohe L, Sendtner M, Kohrle J (2003) Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem J 370(Pt 2):397–402. doi:10.1042/BJ20021853
Schug J, Overton GC (1997) Technical Report CBIL-TR-1997-1001-v0.0
Small-Howard A, Morozova N, Stoytcheva Z, Forry EP, Mansell JB, Harney JW, Carlson BA, Xu XM, Hatfield DL, Berry MJ (2006) Supramolecular complexes mediate selenocysteine incorporation in vivo. Mol Cell Biol 26(6):2337–2346. doi:10.1128/MCB.26.6.2337-2346.2006
Speckmann B, Walter PL, Alili L, Reinehr R, Sies H, Klotz LO, Steinbrenner H (2008) Selenoprotein P expression is controlled through interaction of the coactivator PGC-1alpha with FoxO1a and hepatocyte nuclear factor 4alpha transcription factors. Hepatology 48(6):1998–2006. doi:10.1002/hep.22526
Squires JE, Stoytchev I, Forry EP, Berry MJ (2007) SBP2 binding affinity is a major determinant in differential selenoprotein mRNA translation and sensitivity to nonsense-mediated decay. Mol Cell Biol 27(22):7848–7855. doi:10.1128/MCB.00793-07
Strahle U, Schmid W, Schutz G (1988) Synergistic action of the glucocorticoid receptor with transcription factors. EMBO J 7(11):3389–3395
Tabuchi Y, Kondo T, Suzuki Y, Obinata M (2005) Genes involved in nonpermissive temperature-induced cell differentiation in Sertoli TTE3 cells bearing temperature-sensitive simian virus 40 large T-antigen. Biochem Biophys Res Commun 329(3):947–956. doi:10.1016/j.bbrc.2005.02.065
Teboul M, Guillaumond F, Grechez-Cassiau A, Delaunay F (2008) The nuclear hormone receptor family round the clock. Mol Endocrinol 22(12):2573–2582. doi:10.1210/me.2007-0521
Thisse C, Degrave A, Kryukov GV, Gladyshev VN, Obrecht-Pflumio S, Krol A, Thisse B, Lescure A (2003) Spatial and temporal expression patterns of selenoprotein genes during embryogenesis in zebrafish. Gene Expr Patterns 3(4):525–532. doi:10.1016/S1567-133X(03)00054-1
Tujebajeva RM, Copeland PR, Xu XM, Carlson BA, Harney JW, Driscoll DM, Hatfield DL, Berry MJ (2000) Decoding apparatus for eukaryotic selenocysteine insertion. EMBO Rep 1(2):158–163. doi:10.1093/embo-reports/kvd033
Umesono K, Murakami KK, Thompson CC, Evans RM (1991) Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 65(7):1255–1266. doi:10.1016/0092-8674(91)90020-Y
Vogtli M, Elke C, Imhof MO, Lezzi M (1998) High level transactivation by the ecdysone receptor complex at the core recognition motif. Nucleic Acids Res 26(10):2407–2414. doi:10.1093/nar/26.10.2407
Wade KC, Guttentag SH, Gonzales LW, Maschhoff KL, Gonzales J, Kolla V, Singhal S, Ballard PL (2006) Gene induction during differentiation of human pulmonary type II cells in vitro. Am J Respir Cell Mol Biol 34(6):727–737. doi:10.1165/rcmb.2004-0389OC
Walter PL, Steinbrenner H, Barthel A, Klotz LO (2008) Stimulation of selenoprotein P promoter activity in hepatoma cells by FoxO1a transcription factor. Biochem Biophys Res Commun 365(2):316–321. doi:10.1016/j.bbrc.2007.10.171
Watanabe C, Kim CY, Satoh H (1997) Tissue-specific modification of selenium concentration by acute and chronic dexamethasone administration in mice. Br J Nutr 78(3):501–509. doi:10.1079/BJN19970167
Wingler K, Brigelius-Flohe R (1999) Gastrointestinal glutathione peroxidase. Biofactors 10(2–3):245–249. doi:10.1002/biof.5520100223
Yu MK, Moos PJ, Cassidy P, Wade M, Fitzpatrick FA (2004) Conditional expression of 15-lipoxygenase-1 inhibits the selenoenzyme thioredoxin reductase: modulation of selenoproteins by lipoxygenase enzymes. J Biol Chem 279(27):28028–28035. doi:10.1074/jbc.M313939200
Acknowledgments
This work was supported by CA115616 (PJM) from the National Cancer Institute and P30 CA042014 to Huntsman Cancer Institute for support of core facilities. We thank Drs Hill and Burk for providing the anti-SelP antiserum. We also thank Drs Carol Lim, Michael Franklin, and the reviewers for their helpful suggestions on this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rock, C., Moos, P.J. Selenoprotein P regulation by the glucocorticoid receptor. Biometals 22, 995–1009 (2009). https://doi.org/10.1007/s10534-009-9251-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10534-009-9251-2